[1] 李冉,辛华雯.他克莫司治疗儿童难治性肾病综合征的研究进展[J].中国药师,2017,20(12):2228-2232. [2] Gulati S,Prasa N,Sharma RK,et al.Tacrolimus B new therapy for steroid-resistant nephrotic syndrome in Children[J].Nephrol Dial Transplant,2008,23:910-913. [3] Greenbaum LA,Benndorf R,Smoyer WE.Childhood nephrotic syndrome-current and future therapies[J].Nat Rev Nephrol,2012, 8(8):445-448. [4] Chen Y,Schieppati A,Cai G,et al.Immunosuppression for Membranous Nephropathy:A Systematic Review and Meta-Analysis of 36 Clinical Trials[J].Clin J Am Soc Nephrol,2013,8(5):787-796. [5] 周逸雯,周琰,吴炯,等.CYP3A4、CYP3A5和CYP2D6基因单核苷酸多态性对肾移植术后稳定期患者他克莫司代谢的影响[J].检验医学,2015,30(11):1091-1095. [6] 易鑫,汪江林,周亚男,等.地尔硫卓单用及与氨氯地平或非洛地平联用对肾移植受者他克莫司血药浓度/剂量比的影响[J].中国药房,2015,26(15):2038-2041. [7] 中华医学会儿科分会肾脏病学组.小儿肾小球疾病的临床分类、诊断及治疗[J].中华儿科杂志,2001,39(12):746-747. [8] 中华医学会儿科学分会肾脏学组.儿童常见肾脏疾病诊治循证指南(一):激素敏感、复发/依赖肾病综合征诊治循证指南(试行)[J].中华儿科杂志,2009,47(3):167-170. [9] Cruz JL,Wolff ML,Vanderman AJ,et al.The emerging role of tacrolimus in myasthenia gravis[J].Ther Adv Neurol Disord,2015,8(2):92-103. [10] Aydogan M,Yologlu N,Gacar G,et al.Successful rapid rituximab desensitization in an adolescent patient with nephrotic syndrome:Increase in number of Treg cells after desensitization[J].J Allergy Clin Immunol,2013,132(2):478-480. [11] Chen M,Li H,Li XY,et al.Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy:a multicenter randomized controlled trial[J].Am J Med Sci,2010, 339(3):233-238. [12] Cui W,Lu X,Min X,et al.Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy[J].Braz J Med Biol Res,2017,50(4):e5976. [13] 张艳敏,宋晓翔,王丽峰,等.他克莫司治疗50例儿童激素耐药型肾病综合征的临床研究[J].中华临床医师杂志,2016,10(23):3526-3529. [14] 周优丽,沈增晖,姚云,等.他克莫司联合激素对儿童激素耐药难治性肾病综合征的疗效研究[J].儿科药学杂志,2016,22(3):21-23. [15] Bhimma R,Adhikari M,Asharam K,et al. Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus[J]. Am J Nephrol,2006,26(6):544-551. [16] Haddad M,Lau K,Butani L.Remission of membranoproliferative glomerulonephritis type Ⅰ with the use of tacrolimus[J].Pediatr Nephrol,2007,22(10):1787-1791. [17] Qin HZ,Liu L, Liang SS,et al. Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients[J].BMC Nephrol,2017,18(2):2-9. [18] Westhoff TH,Giet M.Tacrolimus in the treatment of idiopathic nephrotic syndrome[J].Expert Opin Investiq Drugs,2007,16(7):1099-1110. [19] 龚丽娴.地尔硫卓致他克莫司血药浓度升高2例[J].医学信息, 2010,23(6):1650. [20] 李明,宋艳,高雅婷,等.肾移植患者合并用药对他克莫司血药浓度的影响[J].中国合理用药探索杂志,2017,14(4):36-40. [21] 陆迪菲,袁戈恒,郭晓蕙.库欣综合征患者术后管理:糖皮质激素替代治疗[J].中国实用内科杂志,2018,38(7):611-614. [22] 黎晓红.长程大量应用糖皮质激素的不良反应及防治进展[J].临床合理用药杂志,2016,3(9):174-175. [23] 任东亮,张效功,陈清亮.他克莫司联合小剂量激素治疗儿童难治性肾病综合征的临床疗效观察[J].中国现代药物应用杂志,2015,9(18):114-115. |